The AIBE 2026 form correction facility is now active on the official website at allindiabarexamination.com. Candidates can edit their submitte ...

UPESSC B.Ed Assistant Professor Recruitment 2026: The Uttar Pradesh Education Service Selection Commission (UPESSC) has ...

The Arunachal Pradesh Staff Selection Board (APSSB) has released the CGL Recruitment 2026 notification for various Group C ...

Crop residue burning incidents in Haryana surged to 900 in April 2023, doubling from 450 last year, with efforts underway to ...

Focusing on the shift from containment to immediate engagement, the content highlights how officers are trained to make quick ...

Submission supported by data from Phase 3 pivotal AFFIRM study If approved, adult Crohn's disease patients will have an additional option for induction of risankizumab-rzaa ...

AbbVie Inc. (NYSE:ABBV) is one of the best drug stocks to buy according to analysts. AbbVie Inc. (NYSE:ABBV) announced on ...

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced ...

Johnson & Johnson announced that it entered into a definitive agreement to acquire Atraverse Medical. Regeneron struck a drug pricing deal with the Trump administration to reduce prices on drugs for ...

AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease: North Chicago, Illinois Wednesday, April 29, 2026, 1 ...

Studies showing significant improvements in scalp hair coverage support the application for approval for adolescents and adults with severe alopecia areata.

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...